3DR Laboratories
provides hospitals, imaging centers, and radiology practices with consistent,
high quality, 3D post-processed MRI and CT images
Accumen Inc., the leader in healthcare performance, today
announced that it has acquired 3DR Laboratories, the largest and most respected
3D medical post-processing laboratory in the United States.
Accumen’s team members work side-by-side with hospital,
health system, commercial laboratory, payer, and pharmacy clients, providing
strategic solutions, services and technology that deliver sustainable performance
improvements in operations, clinical services, and data management. These
offerings include lab and imaging transformation, consulting, supply chain
optimization, lab outreach, patient blood utilization, test utilization, anemia
management and clinical data exchange. Accumen’s offerings enable its clients
to achieve and exceed - their cost, quality, and service targets, as well as
deliver excellent patient care through evidence-based data and clinical
decision support capabilities.
The addition of 3DR Laboratories to the Accumen portfolio of
companies brings expansion to Accumen’s clinical offerings, as well as depth to
its imaging transformation offering, which is focused on operational
performance in imaging departments and centers across the country bringing
meaningful savings, operational efficiencies and improved patient care.
“We are delighted that 3DR Laboratories is joining our
Clinical Performance Business Unit and further strengthening our imaging
transformation service line. We are very impressed with the high quality and
consistency of 3DR’s computed tomography (CT) and magnetic resonance imaging
(MRI) post-processing work, as well as its strong service-centric reputation
which is enabling radiologists to meet even the most urgent patient needs,”
said Accumen President and CEO Jeff Osborne.
Since it was founded in 2005, 3DR Laboratories has provided
post-processing services to hundreds of hospital radiology departments,
stand-alone imaging centers, and radiology practices, enabling them to obtain
expert processing of their medical imaging cases within hours or even minutes
for emergencies. 3DR Laboratories has processed more than 400,000 cases, and
now has more than 450 active clients nationally.
“At Accumen, we are steadily expanding our portfolio so that
we can help our clients to optimize their performance; whether it be
operational, clinical, or data-focused. We want to assist all healthcare
clients in resolving inefficiencies so they can meet their patient experience
goals, while also preparing for continued reimbursement reductions. Our clients
can then reinvest the time and cost savings achieved through our partnerships
into patient care, so everyone benefits,” added Mr. Osborne.
“Accumen is continuing to aggressively invest into its already
strong imaging transformation offering and we are excited to have become a key
part of their team. This is a great strategic fit because our companies share a
similar vision with complementary cultures and values. Furthermore, we will now
be able to significantly expand the range of services that we can offer to our
clients,” said 3DR’s CEO and Chairman of the Board, David E. Ferguson.
Accumen’s imaging team already has decades of operational
and clinical imaging experience. It also has two well-respected radiologists -
Dr. Carla Harmath and Dr. Jonathan Chung from the University of Chicago
Medicine - on its Medical Advisory Council. Dr. James Brink, Mass General
Radiologist-in-Chief is also a member of Accumen’s Board of Directors.
“Accumen shares our strong commitment to delivering high
quality results and excellent customer service. It is also an exciting
entrepreneurial, team-focused environment in which our employees will thrive,”
said Dr. Robert E. Falk, 3DR founder and Chief Medical Officer.
No changes are expected with respect to 3DR’s excellent
staff – currently consisting of more than 150 employees, 120 of which are
radiologic technologists – or its Louisville, KY main office.
Underscoring 3DR’s commitment to excellence, all its
technologists are specially trained and American Registry of Radiologic
Technologists-certified. 3DR also has an extensive, HIPAA-compliant security
system to safeguard the transmission of case files.
This is Accumen’s third acquisition since being acquired by
Arsenal Capital Partners in January 2019. Accumen acquired Halfpenny
Technologies Inc., a provider of clinical data exchange platforms for health
systems, commercial labs, and health plans. Accumen also acquired Patient
Readiness Institute’s MyBloodHealth®, a virtual, pre-operative anemia
management solution.
Edgemont Partners represented 3DR Laboratories and its
ownership group through 3DR’s transaction process, and Healthcare Growth
Partners (HGP) represented Accumen and Arsenal. No financial details about
these transactions have been disclosed.
About 3DR
Laboratories
Based in Louisville, KY, 3DR Laboratories provides 24/7
access to expert radiological technologists who perform superior 3D medical
image post processing.
For more information, visit 3drinc.com.
About Accumen Inc.
At Accumen, our focus is healthcare performance. Accumen
utilizes healthcare technology along with our expert performance team members
to drive significant value to hospital, health system, commercial laboratory
and payer clients, providing strategic solutions, services and technology that
deliver sustainable performance improvements in operations, clinical services,
and data management. These offerings include lab and imaging transformation,
consulting, supply chain optimization, lab outreach, patient blood utilization,
test utilization, anemia management and clinical data exchange. Accumen’s
offerings enable its clients to achieve and exceed their cost, quality, and
service targets, as well as deliver excellent patient care through
evidence-based data and clinical decision support capabilities.
We share the belief that performance matters. We are
inspired to improve operational, clinical, and data performance across the
healthcare industry because transformational change will make healthcare better
for our clients, our communities and our families.
Disclaimer: Neither
Accumen nor 3DR has any authority, responsibility, or liability with respect to
any clinical decisions made by – or in connection with – a provider’s
laboratory, patient blood management, or other operations. Nothing herein and
no aspect of any services provided by Accumen or 3DR is intended – or shall be
deemed – to subordinate, usurp, or otherwise diminish any providers’ sole
authority and discretion with respect to all clinical decision-making for its
patients.
For more information, visit Accumen.com.